IP Library Granted Patent US 9,920,380
Granted Patent B2
US 9,920,380 · App. 13/794,299 · Granted Mar 20, 2018

Methods for detection and quantification of analytes in complex mixtures

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,920,380
App. No.
13/794,299
Granted
Mar 20, 2018
Kind
B2
Abstract

The invention provides a diverse population of uniquely labeled probes, containing about thirty or more target specific nucleic acid probes each attached to a unique label bound to a nucleic acid. Also provided is a method of producing a population of uniquely labeled nucleic acid probes. Also provided is a method of detecting a nucleic acid analyte. The method consists of (a) contacting a mixture of nucleic acid analytes under conditions sufficient for hybridization with a plurality of target specific nucleic acid probes each having a different specifier; (b) contacting the mixture under conditions sufficient for hybridization with a corresponding plurality of anti-genedigits each having a unique label, the plurality of anti-genedigits having a diversity sufficient to uniquely hybridize to genedigits within the specifiers, and (c) uniquely detecting a hybridized complex between one or more analytes in the mixture, a target specific probe, and an anti-genedigit.

Claims (26)

1. A composition comprising:

(a) a first probe comprising

(i) a region that selectively binds to a first target specific sequence of a nucleic acid analyte, and

(ii) a region comprising a plurality of label-attachment positions linked together, each label-attachment position being of a predetermined nucleotide sequence, wherein at least two of the label-attachment positions comprise a repeated core element, and wherein

a first label-attachment position is attached to a complementary nucleic acid sequence comprising a first plurality of label monomers, wherein the first plurality of label monomers comprises a first label; and

at least a second label-attachment position is attached to at least a second complementary nucleic acid sequence comprising at least a second plurality of label monomers, wherein the second plurality of label monomers comprises at least a second label;

wherein the first label and the second label are spatially-separable for resolution of the first label from the second label; and

(b) a second probe comprising

(i) a region that selectively binds to a second target specific sequence of the nucleic acid analyte, wherein the first target-specific sequence and the second target-specific sequence bind to different regions of the same nucleic acid analyte, and

(ii) an affinity tag.

2. The composition of claim 1 , wherein the first probe further comprises an affinity tag.

3. The composition of claim 1 , wherein the affinity tag is a biotin tag.

4. The composition of claim 2 , wherein the affinity tag is a biotin tag.

5. The composition of claim 1 , wherein the complementary nucleic acid sequence is DNA.

6. The composition of claim 1 , wherein the complementary nucleic acid sequence is RNA.

7. The composition of claim 1 , wherein the complementary nucleic acid sequence is a dendrimer.

8. The composition of claim 1 , wherein the plurality of label-attachment positions comprises at least four label-attachment positions.

9. The composition of claim 1 , wherein the plurality of label-attachment positions are in a predetermined order within the probe.

10. The composition of claim 1 , wherein at least two of the label-attachment positions have different nucleotide sequences.

11. The composition of claim 1 , wherein each label-attachment position has a different nucleotide sequence.

12. The composition of claim 11 , wherein the nucleotide sequence of each label-attachment position differs by at least two nucleotides.

13. The composition of claim 1 , wherein the label-attachment positions are directly linked.

14. The composition of claim 1 , wherein the label-attachment positions are linked via intervening or adapting sequences.

15. The composition of claim 1 , wherein each label monomer comprises a fluorescent moiety.

16. The composition of claim 1 , wherein the affinity tag is a digoxigenin tag.

17. The composition of claim 2 , wherein the affinity tag is a digoxigenin tag.

Assignments (3)
TERMINATION AND RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Mar 10, 2020
From: CRG SERVICING LLC
To: NANOSTRING TECHNOLOGIES, INC.
Reel/Frame 052136/0021 →
SECURITY INTEREST Recorded Oct 16, 2018
From: NANOSTRING TECHNOLOGIES, INC.
To: CRG SERVICING LLC
Reel/Frame 047240/0439 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2013
From: DIMITROV, KRASSEN; DUNAWAY, DWAYNE
To: THE INSTITUTE FOR SYSTEMS BIOLOGY
Reel/Frame 029970/0547 →